Evotec has reported that the acquisition of the controlling majority stake of Research Support International (RSIPL) has been successfully completed and that RSIPL is a 70%, majority owned subsidiary of Evotec as of August 31, 2009.
The purchase price for the 70% controlling majority stake payable, before adjustments, to DIL is E2.8m in cash, a portion of which includes a potential earn-out. Evotec has a call option to purchase the remaining 30% from DIL in the future in the event of a change of control.
Reportedly, following the transaction, RSIPL will be integrated into the value chain of Evotec’s operations in Hamburg (Germany), Abingdon (UK) and Singapore.